A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
DRUG

CDX-301

"CDX-301, administered in multiple dosages and frequencies depending on arm:~n=3-6 at between 1-75 μg/kg over 5 days~n=3-6 at 25 μg/kg over 7 days~n=3-6 at 25 μg/kg over 10 days"

Trial Locations (1)

10065

Rockefeller University, New York

Sponsors
All Listed Sponsors
lead

Celldex Therapeutics

INDUSTRY